G Davì Selected Research

G Davì Research Topics

Disease

5	Inflammation (Inflammations) 07/2008 - 01/2005
4	Type 2 Diabetes Mellitus (MODY) 04/2010 - 02/2003
4	Atherosclerosis 12/2007 - 05/2000
4	Obesity 05/2007 - 11/2003
3	Weight Loss (Weight Reduction) 05/2007 - 11/2003
2	Neoplasms (Cancer) 10/2016 - 01/2007
2	Myocardial Ischemia (Ischemic Heart Diseases) 05/2010 - 08/2000
2	Thrombosis (Thrombus) 12/2007 - 01/2007
2	Vascular Diseases (Vascular Disease) 12/2007 - 01/2005
2	Diabetes Mellitus 06/2005 - 02/2003
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2005 - 11/2003
2	Hypercholesterolemia 01/2005 - 05/2000
2	Cystic Fibrosis (Mucoviscidosis) 04/2004 - 10/2000
1	Carcinoma (Carcinomatosis) 10/2016
1	Thromboembolism 05/2010
1	Heart Failure 05/2010
1	Vascular System Injuries 07/2008
1	Necrosis 12/2007
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2007
1	Hypertension (High Blood Pressure) 04/2006
1	Body Weight (Weight, Body) 10/2005
1	Insulin Resistance 10/2005
1	Disease Progression 01/2005
1	Homocystinuria 01/2005
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2005
1	Hyperglycemia 08/2004
1	Hyperhomocysteinemia 09/2001
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 09/2001
1	Ischemia 08/2000
1	Unstable Angina 08/2000
1	Stable Angina 08/2000

Drug/Important Bio-Agent (IBA)

4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2016 - 08/2000
4	ThromboxanesIBA 05/2010 - 08/2000
4	CD40 Ligand (CD40L)IBA 12/2007 - 04/2004
3	Arachidonic Acid (Vitamin F)IBA 08/2004 - 08/2000
2	CytokinesIBA 12/2007 - 10/2005
2	Biomarkers (Surrogate Marker)IBA 01/2007 - 04/2006
2	Vitamin E FDA LinkGeneric 01/2005 - 08/2000
2	AntioxidantsIBA 01/2005 - 08/2000
2	Oxidants (Oxidizing Agents)IBA 01/2005 - 08/2000
2	LipidsIBA 02/2003 - 05/2000
2	8-epi-prostaglandin F2alphaIBA 10/2000 - 08/2000
2	CreatinineIBA 10/2000 - 08/2000
1	VimentinIBA 10/2016
1	Cyclin B1IBA 10/2016
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 10/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2016
1	Transcription Factors (Transcription Factor)IBA 10/2016
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 05/2010
1	Hemoglobin AIBA 04/2010
1	Acarbose FDA LinkGeneric 04/2010
1	Hypoglycemic Agents (Hypoglycemics)IBA 04/2010
1	Angiotensin IIIBA 07/2008
1	Glycoproteins (Glycoprotein)IBA 12/2007
1	ChemokinesIBA 12/2007
1	Hemostatics (Antihemorrhagics)IBA 05/2007
1	triflusalIBA 12/2005
1	Messenger RNA (mRNA)IBA 10/2005
1	Interleukin-10 (Interleukin 10)IBA 10/2005
1	AdiponectinIBA 10/2005
1	F2-Isoprostanes (F2 Isoprostanes)IBA 01/2005
1	Antiphospholipid AntibodiesIBA 01/2005
1	VitaminsIBA 01/2005
1	IsoprostanesIBA 08/2004
1	Platelet Membrane GlycoproteinsIBA 08/2004
1	Membrane LipidsIBA 08/2004
1	LeptinIBA 11/2003
1	Hormones (Hormone)IBA 11/2003
1	Proteins (Proteins, Gene)FDA Link 02/2003
1	Tissue Plasminogen Activator (Alteplase)FDA Link 09/2001
1	von Willebrand FactorIBA 09/2001
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 10/2000
1	Ibuprofen (Motrin)FDA LinkGeneric 10/2000
1	nimesulide (Aulin)IBA 10/2000
1	Prostaglandins FIBA 10/2000
1	EnzymesIBA 05/2000
1	P-SelectinIBA 05/2000
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2000
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 05/2000
1	Fluvastatin FDA Link 05/2000

Therapy/Procedure

3	Therapeutics 05/2010 - 05/2000
1	Chemoprevention 10/2016
1	Glycemic Control 08/2004